quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:46:45·79d
INSIDERFiling
Jamf Holding Corp. logo

Director Leite Etalvina returned $499,645 worth of shares to the company (38,287 units at $13.05), closing all direct ownership in the company (SEC Form 4)

JAMF· Jamf Holding Corp.
Technology
Original source

Companies

  • JAMF
    Jamf Holding Corp.
    Technology

Recent analyst ratings

  • Oct 30UpdateMizuho$13.00
  • Mar 18UpdateMorgan Stanley-
  • Feb 6UpdateAnalyst$20.00
  • Oct 14UpdateMorgan Stanley$20.00
  • Sep 3UpdateGoldman$21.00
  • Jan 12UpdateBarclays$20.00

Related

  • SEC73d
    SEC Form 15-12G filed by Jamf Holding Corp.
  • SEC77d
    SEC Form SCHEDULE 13G filed by Jamf Holding Corp.
  • INSIDER79d
    Director Klausmeyer Kevin returned $725,032 worth of shares to the company (55,558 units at $13.05), closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Director Hager Dean returned $3,713,221 worth of shares to the company (284,538 units at $13.05), closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Director Durand Andre Wong returned $1,651,099 worth of shares to the company (126,521 units at $13.05), closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Chief Innovation Officer Wudi Jason returned $4,877,333 worth of shares to the company (373,742 units at $13.05), closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    CTO Tschida Beth returned $6,231,832 worth of shares to the company (477,535 units at $13.05), closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    CFO Rudow David returned $5,395,222 worth of shares to the company (413,427 units at $13.05), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022